Evogene Ltd.
EVGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $8 | $7 | $15 |
| Short-Term Investments | $10 | $3 | $2 | $0 |
| Receivables | $0 | $2 | $3 | $1 |
| Inventory | $2 | $2 | $2 | $2 |
| Other Curr. Assets | $2 | $13 | $1 | $3 |
| Total Curr. Assets | $20 | $29 | $17 | $22 |
| Property Plant & Equip (Net) | $3 | $4 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $12 | $12 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $3 | $3 | $3 |
| Total NC Assets | $6 | $6 | $19 | $20 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $26 | $34 | $34 | $40 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $1 | $1 |
| Short-Term Debt | $1 | $11 | $11 | $11 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $1 |
| Other Curr. Liab. | $3 | $3 | $3 | $6 |
| Total Curr. Liab. | $4 | $15 | $16 | $19 |
| LT Debt | $2 | $2 | $2 | $2 |
| Deferred Rev, NC | $0 | $4 | $4 | $4 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $6 | $6 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $3 | $3 |
| Total Liabilities | $6 | $22 | $22 | $25 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$277 | -$281 | -$277 | -$274 |
| AOCI | $278 | $277 | $273 | $272 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $1 | -$4 | -$4 | -$1 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $16 | $16 | $16 | $16 |
| Total Liab. & Tot. Equity | $26 | $34 | $34 | $40 |
| Net Debt | -$3 | $4 | $5 | -$2 |